Literature DB >> 6993188

Morphine-induced hyperglycemia: role of insulin and glucagon.

E Ipp, V Schusdziarra, V Harris, R H Unger.   

Abstract

An iv bolus injection of 0.5 mg/kg morphine, about twice the therapeutic dose, caused plasma glucose to rise more than 120 mg/dl in alloxan-diabetic conscious dogs but had little effect on conscious normal dogs. Plasma glucagon rose in the diabetic and nondiabetic groups by 30 +/- 10 and 100 +/- 29 pg/ml, respectively, but insulin levels increased significantly only in the nondiabetics. The hyperglycemic action on morphine may, at least in part, be the result of an increase in glucagon secretion without a sufficient accompanying release of insulin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993188     DOI: 10.1210/endo-107-2-461

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

2.  Modulation of post-prandial insulin release by ingested opiate-like substances in dogs.

Authors:  V Schusdziarra; A Holland; R Schick; A de la Fuente; M Klier; V Maier; V Brantl; E F Pfeiffer
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

3.  Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine.

Authors:  A Ceriello; D Giugliano; P Dello Russo; S Sgambato; F D'Onofrio
Journal:  Diabetologia       Date:  1982-05       Impact factor: 10.122

4.  Glucose tolerance in opiate addicts.

Authors:  P P Vescovi; A Pezzarossa; R Caccavari; G Valenti; U Butturini
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

Review 5.  Drug-Induced Hyperglycaemia and Diabetes.

Authors:  Neila Fathallah; Raoudha Slim; Sofien Larif; Houssem Hmouda; Chaker Ben Salem
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

Review 6.  Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.

Authors:  Kimberly N Walter; Julie A Wagner; Eda Cengiz; William V Tamborlane; Nancy M Petry
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

7.  Beta-endorphin inhibits glucose production in the conscious dog.

Authors:  P M Radosevich; P E Williams; J R McRae; W W Lacy; D N Orth; N N Abumrad
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Effects of morphine on glucose homeostasis in the conscious dog.

Authors:  P M Radosevich; P E Williams; D B Lacy; J R McRae; K E Steiner; A D Cherrington; W W Lacy; N N Abumrad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Authors:  Prabhat Singh; Bhupesh Sharma; Surbhi Gupta; B M Sharma
Journal:  Psychopharmacology (Berl)       Date:  2014-07-26       Impact factor: 4.530

10.  Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man.

Authors:  R Caldara; G P Testori; C Ferrari; M Romussi; P Rampini; M Borzio; C Barbieri
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.